The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

OBJECTIVE: This manuscript aims to provide an overview of the unique considerations and best practice principles associated with the manufacture of human viral challenge agents. RESULTS: Considerations are discussed on the entire process from strain and viral source selection through manufacturing,...

Descripción completa

Detalles Bibliográficos
Autores principales: Catchpole, Andrew P., Fullen, Daniel J., Noulin, Nicolas, Mann, Alex, Gilbert, Anthony S., Lambkin-Williams, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114718/
https://www.ncbi.nlm.nih.gov/pubmed/30157933
http://dx.doi.org/10.1186/s13104-018-3636-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114718/
https://www.ncbi.nlm.nih.gov/pubmed/30157933
http://dx.doi.org/10.1186/s13104-018-3636-7

Ejemplares similares